Research Report University Hospital for clinical assessment C25003

Abstract

A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Keywords

• Hodgkin Lymphoma
• A+AVD
• ABVD